Today, a Director at Zogenix (ZGNX), Roger Hawley, sold shares of ZGNX for $826.8K.
In addition to Roger Hawley, one other ZGNX executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Currently, Zogenix has an average volume of 604.3K.
Based on 3 analyst ratings, the analyst consensus is Strong Buy with an average price target of $67.00, reflecting a 68.3% upside.
The insider sentiment on Zogenix has been neutral according to 13 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Roger Hawley’s trades have generated a -10.6% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday.
